| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner, Director By Deputization | Director, 10% Owner, * Director By Deputization | 10% Owner +10 more
37 companies
Flynn James E is a 10% Owner, *possible Member Of 10% Group at AdaptHealth Corp. with holdings across 37 companies. Recent SEC Form 4 filings include 4 buys and 39 sells.
Estimated insider holdings value: $1849.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2018 | GYRE Gyre Therapeutics, Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 71,778 | $30.53 | $2,191,045.03 | -1.3% | |
| Feb 21, 2018 | AHCO Adapthealth Corp. | Director, 10% Owner, *director By Deputization | Buy | 2,500,000 | $0.00 | - | New | |
| Nov 30, 2017 | TARA Protara Therapeutics, Inc. | Director, *director By Deputization | Sell | 110,557 | $1.75 | $193,474.75 | -100% | |
| Nov 30, 2017 | TARA Protara Therapeutics, Inc. | Director, *director By Deputization | Buy | 110,557 | $1.75 | $193,474.75 | +127.3% | |
| Oct 10, 2017 | RYTM Rhythm Pharmaceuticals, Inc. | 10% Owner, Possible Member Of 10% Group | Buy | 355,000 | $17.00 | $6,035,000.00 | +61.0% | |
| Apr 27, 2017 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 426,954 | $11.66 | $4,978,114.79 | -9.7% | |
| Apr 13, 2017 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 150,000 | $11.00 | $1,650,000.00 | -6.2% | |
| Apr 11, 2017 | EHTH Ehealth, Inc. | 10% Owner, Possible Members Of 10% Group | Sell | 232,101 | $11.38 | $2,641,690.82 | -3.1% | |
| Sep 23, 2016 | VNDA Vanda Pharmaceuticals Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 1,120,461 | $16.56 | $18,559,970.78 | -10.6% | |
| Sep 19, 2016 | VNDA Vanda Pharmaceuticals Inc. | 10% Owner, Possible Member Of 10% Group | Sell | 547,886 | $15.66 | $8,582,620.53 | -3.2% |